📣 VC round data is live. Check it out!

7FIT Valuation Multiples

Discover revenue and EBITDA valuation multiples for 7FIT and similar public comparables like Aqua Bio Technology, Giglio, BioRegenx, Webuy Global and more.

7FIT Overview

About 7FIT

7FIT SA is engaged in the operation of online supplement store. The company through its website offers a wide range of bodybuilding supplements for athletes.


Founded

N/A

HQ

Poland

Employees

8

Website

triceps.pl

Financials (FY)

Revenue: $10M
EBITDA: $1M

EV

$9M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

7FIT Financials

7FIT reported last fiscal year revenue of $10M and EBITDA of $1M.

In the same fiscal year, 7FIT generated $3M in gross profit, $1M in EBITDA, and $787K in net income.


7FIT P&L

In the most recent fiscal year, 7FIT reported revenue of $10M and EBITDA of $1M.

7FIT is profitable as of last fiscal year, with gross margin of 31%, EBITDA margin of 11%, and net margin of 8%.

See analyst estimates for 7FIT
Last FY202320242025202620272028
Revenue$10M$7M$7M$10M
Gross Profit$3M$2M$2M$3M
Gross Margin31%31%29%31%
EBITDA$1M$699K$485K$1M
EBITDA Margin11%11%6%11%
EBIT Margin10%11%6%10%
Net Profit$787K$489K$288K$787K
Net Margin8%8%4%8%
Net Debt$804K

Financial data powered by Morningstar, Inc.

7FIT Stock Performance

7FIT has current market cap of $8M, and enterprise value of $9M.

Market Cap Evolution


7FIT's stock price is $4.69.

7FIT share price increased by 6.9% in the last 30 days, and by 132.5% in the last year.

7FIT has an EPS (earnings per share) of $0.44.

See more trading valuation data for 7FIT
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$9M$8M4.2%6.9%15.3%132.5%$0.44

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

7FIT Valuation Multiples

7FIT trades at 0.9x EV/Revenue multiple, and 8.2x EV/EBITDA.

See NTM and 2027E valuation multiples for 7FIT

7FIT Financial Valuation Multiples

As of May 8, 2026, 7FIT has market cap of $8M and EV of $9M.

7FIT has a P/E ratio of 10.7x.

Last FY202320242025202620272028
EV/Revenue0.9x1.4x1.2x0.9x
EV/EBITDA8.2x13.2x19.0x8.2x
EV/EBIT9.3x13.3x21.7x9.3x
EV/Gross Profit3.1x4.6x4.2x3.1x
P/E10.7x17.2x29.2x10.7x
EV/FCF(121.4x)39.2x(38.9x)(121.4x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified 7FIT Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

7FIT Margins & Growth Rates

In the most recent fiscal year, 7FIT reported gross margin of 31%, EBITDA margin of 11%, and net margin of 8%.

See estimated margins and future growth rates for 7FIT

7FIT Margins

Last FY20242025202720282029
Gross Margin31%29%31%
EBITDA Margin11%6%11%
EBIT Margin10%6%10%
Net Margin8%4%8%
FCF Margin(1%)(3%)(1%)

7FIT Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth15%31%
Gross Profit Growth9%36%
EBITDA Growth(31%)131%
EBIT Growth(39%)134%
Net Profit Growth(41%)173%
FCF Growth(201%)(68%)

Data powered by FactSet, Inc. and Morningstar, Inc.

7FIT Operational KPIs

7FIT's revenue per employee in the last FY averaged $1.2M, while opex per employee averaged $0.2M for the same period.

Access forward-looking KPIs for 7FIT
Last FY202320242025202620272028
Revenue per Employee$1.2M
Opex per Employee$0.2M
Opex to Revenue20%20%24%20%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Aqua Bio Technology138.1x(32.3x)
Giglio0.1x(54.4x)
BioRegenx5.9x(9.3x)
Webuy Global0.4x(2.0x)
Refine Group0.4x0.8x
Arctic Bioscience3.3x(3.6x)
PMGC Holdings10.8x(0.9x)
Pharmena19.7x(11.9x)

This data is available for Pro users. Sign up to see all 7FIT competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About 7FIT

Where is 7FIT headquartered?7FIT is headquartered in Poland.
How many employees does 7FIT have?As of today, 7FIT has over 8 employees.
Is 7FIT publicly listed?Yes, 7FIT is a public company listed on Warsaw Stock Exchange.
What is the stock symbol of 7FIT?7FIT trades under 7FT ticker.
When did 7FIT go public?7FIT went public in 2012.
Who are competitors of 7FIT?7FIT main competitors include Aqua Bio Technology, Giglio, BioRegenx, Webuy Global, Refine Group, Arctic Bioscience, PMGC Holdings, Pharmena, NUTEX, Kumulus Vape.
What is the current market cap of 7FIT?7FIT's current market cap is $8M.
What is the current revenue of 7FIT?7FIT's last fiscal year revenue is $10M.
What is the current EV/Revenue multiple of 7FIT?Current revenue multiple of 7FIT is 0.9x.
Is 7FIT profitable?No, 7FIT is not profitable.
How many companies 7FIT has acquired to date?7FIT hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies 7FIT has invested to date?7FIT hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to 7FIT

Lists including 7FIT

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial